CD19 Protéines
(CD19 Molecule (CD19))
Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. [provided by RefSeq, Jul 2008].
Filtrer les résultats:
48 Résultats
CD19
Origine: Souris
Hôte: HEK-293 Cells
Recombinant
> 90 %
Inactive
CD19
Origine: Humain
Hôte: HEK-293 Cells
Recombinant
> 95 % by SDS-PAGE.
Active
CD19
Origine: Humain
Hôte: Baculovirus infected Insect Cells
Recombinant
> 85 %
SDS
CD19
Origine: Humain
Hôte: HEK-293 Cells
Recombinant
The purity of the protein is greater than 85 % as determined by SDS-PAGE and Coomassie blue staining.
ScA, IA, AM, ADA
CD19
Origine: Cynomolgus
Hôte: HEK-293 Cells
Recombinant
The purity of the protein is greater than 85 % as determined by SDS-PAGE and Coomassie blue staining.
ScA, IA, AM, ADA
CD19
Origine: Humain
Hôte: HEK-293 Cells
Recombinant
The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
ScA, IA, AM, ADA
CD19
Origine: Humain
Hôte: HEK-293 Cells
Recombinant
The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
ScA, IA, AM, ADA
CD19
Origine: Humain
Hôte: HEK-293 Cells
Synthetic Nanodisc
Imm, ELISA, cryo-EM, PhD, SPR
CD19
Origine: Humain
Hôte: HEK-293 Cells
Recombinant
> 80 % as determined by SDS-PAGE and Coomassie blue staining
STD, AbP
1 image
CD19
Origine: Humain
Hôte: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
1 image
CD19
Origine: Cynomolgus, Macaque rhésus
Hôte: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
1 image
CD19
Origine: Cynomolgus, Macaque rhésus
Hôte: HEK-293 Cells
Recombinant
>95 % as determined by reduced SDS-PAGE.
1 image
CD19
Origine: Callithrix jacchus
Hôte: Levure
Recombinant
> 90 %
ELISA
CD19
Origine: Humain
Hôte: HEK-293 Cells
Recombinant
>90 % as determined by SDS-PAGE.
Dernières publications pour nos CD19 Protéines
: "Targeting CD79b for Chimeric Antigen Receptor T-Cell Therapy of B-Cell Lymphomas." dans: Targeted oncology, Vol. 15, Issue 3, pp. 365-375, (2020) (PubMed).
: "Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells." dans: Molecular therapy oncolytics, Vol. 18, pp. 149-160, (2020) (PubMed).
: "Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy." dans: Cytotherapy, Vol. 22, Issue 12, pp. 734-743, (2020) (PubMed).
: "Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy." dans: Journal for immunotherapy of cancer, Vol. 8, Issue 2, (2020) (PubMed).
: "TREM1/Dap12-based CAR-T cells show potent antitumor activity." dans: Immunotherapy, Vol. 11, Issue 12, pp. 1043-1055, (2019) (PubMed).
: "Chimeric antigen receptors that trigger phagocytosis." dans: eLife, Vol. 7, (2018) (PubMed).
: "Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 197, Issue 5, pp. 1884-92, (2017) (PubMed).
: "Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells." dans: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 25, Issue 4, pp. 949-961, (2017) (PubMed).
: "A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors." dans: Journal of translational medicine, Vol. 11, pp. 23, (2013) (PubMed).
: "Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells." dans: Molecular therapy oncolytics, Vol. 18, pp. 149-160, (2020) (PubMed).
: "Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy." dans: Cytotherapy, Vol. 22, Issue 12, pp. 734-743, (2020) (PubMed).
: "Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy." dans: Journal for immunotherapy of cancer, Vol. 8, Issue 2, (2020) (PubMed).
: "TREM1/Dap12-based CAR-T cells show potent antitumor activity." dans: Immunotherapy, Vol. 11, Issue 12, pp. 1043-1055, (2019) (PubMed).
: "Chimeric antigen receptors that trigger phagocytosis." dans: eLife, Vol. 7, (2018) (PubMed).
: "Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 197, Issue 5, pp. 1884-92, (2017) (PubMed).
: "Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells." dans: Molecular therapy : the journal of the American Society of Gene Therapy, Vol. 25, Issue 4, pp. 949-961, (2017) (PubMed).
: "A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors." dans: Journal of translational medicine, Vol. 11, pp. 23, (2013) (PubMed).
Pseudonymes pour CD19 Protéines
CD19 molecule (CD19) ProtéinesCD19 antigen (Cd19) Protéines
CD19 molecule (Cd19) Protéines
AW495831 Protéines
B4 Protéines
CD19 Protéines
CVID3 Protéines
Avez-vous cherché autre chose?
- CD180 Protéines
- CD177 Protéines
- CD164L2 Protéines
- CD164 Protéines
- CD163 Protéines
- CD161 Protéines
- CD160 Protéines
- CD16 Protéines
- CD151 Protéines
- CD15 Protéines
- CD147 Protéines
- CD14 Protéines
- CD137 Protéines
- CD131 Protéines
- CD130/gp130 Protéines
- CD11c Protéines
- CD11b Protéines
- CD109 Protéines
- CD103 Protéines
- CD101 Protéines
- CD1a Protéines
- CD1b Protéines
- CD1c Protéines
- CD1d Protéines
- CD1e Protéines
- CD2 Protéines
- CD20 Protéines
- CD200 Protéines
- CD200R1 Protéines
- CD200R1L Protéines
- CD200R4 Protéines
- CD207 Protéines
- CD209a Antigen Protéines
- CD209b Antigen Protéines
- CD209d Antigen Protéines
- CD21 Protéines
- CD22 Protéines
- CD226 Protéines
- CD235a/GYPA Protéines
- CD235b/GYPB Protéines
Vous êtes ici:
